Medicine & Life Sciences

1. Uterine Cervical Neoplasms 100%
2. Carcinoma 98%
3. Endometrial Neoplasms 86%
4. Ovarian Neoplasms 85%
5. Neoplasms 78%
6. Carcinosarcoma 70%
7. Survival 66%
8. Cell Biology 58%
9. Early Detection of Cancer 50%
10. Ovarian Epithelial Carcinoma 47%
11. Tubal Sterilization 46%
12. Salpingectomy 44%
13. Guidelines 44%
14. Colposcopy 42%
15. Cervical Intraepithelial Neoplasia 42%
16. Platinum 38%
17. Drug Therapy 37%
18. Therapeutics 35%
19. Mutation 34%
20. Randomized Controlled Trials 32%
21. Robotics 32%
22. Vaginal Neoplasms 31%
23. Vaccination 31%
24. Cervix Uteri 30%
25. African Continental Ancestry Group 30%
26. Lymph Node Excision 30%
27. Recurrence 29%
28. Vulvar Neoplasms 29%
29. rucaparib 27%
30. Fallopian Tubes 27%
31. Cost-Benefit Analysis 26%
32. Papillomavirus Vaccines 26%
33. Adenocarcinoma 25%
34. Histology 25%
35. Papanicolaou Test 25%
36. Sentinel Lymph Node Biopsy 24%
37. Progression-Free Survival 24%
38. Cytosine Deaminase 24%
39. Endometrial Stromal Sarcoma 23%
40. Papillomavirus Infections 23%
41. Referral and Consultation 23%
42. Neoplasm Metastasis 22%
43. Adenocarcinoma in Situ 22%
44. Salpingo-oophorectomy 22%
45. Granulosa Cell Tumor 22%
46. Credentialing 22%
47. Uterine Cervical Dysplasia 22%
48. Population 21%
49. human ERBB2 protein 20%
50. European Continental Ancestry Group 20%